Research & Development News
Research & Development news
-
News Modified poliovirus vaccine shows potential for fighting recurrent glioblastoma
Scientists have found a modified poliovirus vaccine may be beneficial for treating recurrent glioblastoma -
News Drug therapies to inhibit Dkk1 function may limit arteriosclerotic disease, study finds
Targeting drug therapies at Dkk1 functioning could limit arteriosclerotic disease, researchers say -
News Thyroxin may treat autism and foetal alcohol spectrum disorder
The thyroid hormone has proved effective in treating symptoms present in rats. -
News L-methylfolate shows promise for major depressive disorder patients
L-methylfolate could help patients who do not respond to selective serotonin reuptake inhibitor antidepressants. -
News Bazedoxifene could target breast cancer and osteoporosis
Bazedoxifene's effects on oestrogen mean it may protect against both osteoporosis and breast cancer. -
News Encouraging clinical trial results for multiple myeloma treatment
ACY-1215 inhibits the enzyme HDAC6 in order to encourage apoptosis in multiple myeloma cells. -
News Cohort size may have major impact on clinical trial budget
A new report indicates that clinical trial costs are closely tied to patient enrollment. -
News Insulin inhaler phase 3 clinical trial completed
The inhaler delivers insulin to type 2 diabetes patients prior to a meal to prevent hyperglycemia. -
News Vasomera phase 1 clinical trial successfully completed
The drug could treat people with cardiopulmonary disease. -
News Clinical trial examining how to destroy cancerous stem cells
A clinical trial examining how to destroy cancerous stem cells is to get underway. -
News Anti metastasis drug tested in clinical trial
The drug may prevent metastasis by inhibiting the migratory processes in epithelial cells. -
News Clinical trial for soft tissue sarcoma drug on track
The drug could deliver higher doses of doxorubicin without the same levels of toxicity. -
News Medivation and Astellas Pharma announce TNBC Phase 2 trials
Medivation and Astellas Pharma have announced Phase 2 of TNBC trials. -
News InGeneron launches new stem cell clinical trial
InGeneron is looking to see how effective the utilisation of regenerative cells from a patient can be in healing a knee cartilage. -
News Study shows progress in targeted drugs using molecular robots
A study at the Hospital For Special Surgery has shown progress towards methods to better target drugs -
News Nerviano and Servier announce collaboration and license for novel anticancer drug
A deal has been reached between Nerviano and Servier for a novel anticancer drug. -
News Altravax receives grant for vaccination development
Grants will be provided to Altravax so it can research vaccines for dengue virus and chronic hepatitis B. -
News Plaque psoriasis spray gets go-ahead from US FDA
A topical spray for psoriasis has been approved for a new drug application. -
News Boehringer Ingelheim to join Structural Genomics Consortium
New partnership could pave the way for previously undiscovered cures -
News Spontaneous mutations may cause 10% of congenital heart disease cases
De novo mutations in the developing heart may be the cause of congential heart disease -
News Safer form of acetaminophen may be on the horizon
Researchers may have identified two non-toxic alternatives to acetaminophen. -
News EMA approves Votrient following positive clinical trial results
The EMA has approved Votrient following the publication of positive clinical trial results. -
News Clinical trial transparency law 'largely ignored'
Ben Goldacre is calling for full disclosure of clinical trial results. -
News MiFusion ENTceps may reduce pain in tonsillectomy patients
The surgical device helps seal tonsillectomy wounds in order to speed up the recovery process. -
News Acurian releases clinical trial enrollment cost reports
The reports help investors and manufacturers to estimate the cost of a study. -
News Removing benign tumours could eliminate high blood pressure
A team of researchers say removing benign tumours in the adrenal glands could cure high blood pressure. -
News Ultrasound can reduce kidney injuries
Ultrasound can be used to prevent acute kidney injury following surgery. -
News Study says abatacept and adalimumab offer comparable benefits in RA
Clinical outcomes of ABA and ADA treatments were comparable in an RA patient cohort. -
News Cholesterol-lowering drug shows promise in clinical trial
The drug could prove effective in populations of patients intolerant to statins. -
News Software suite aids in drug discovery
Centara has upgraded its SYBYL-X drug development software suite. -
News Promising results from MS therapy trial
The treatment may help to reduce immune system myelin resistance by up to 75 per cent. -
News Drug may prevent PTSD symptoms following trauma
Laboratory mice responded positively to Oprl1, and the next step is to determine its effect on humans. -
News New drug may kill cancer cells and prevent metastasis
Scientists have developed a compound that could both kill melanoma cells and prevent metastasis. -
News Results of Next Wave brain stimulation device trial unveiled
The Next Wave approach improved patients' total field of vision by 24 per cent. -
News Galderma trialling new muscle relaxant
The muscle relaxant will serve as an alternative in territories where Galderma cannot distribute Azzalure or Dysport. -
News Biogen to acquire full rights to Tysabri
The company will purchase Elan's 50 per cent stake in the commercial and strategic. -
News Stem cell treatment appears to improve mobility in stroke victims
Could stem cell treatment be the way to improve outcomes for stroke patients? -
News Synthesised small molecule could be used to combat prostate cancer, study suggests
Research has suggested a synthesised small molecule could be used to prevent the growth of prostate cancer cells -
News Epilepsy drug may stave off noise-induced tinnitus, study finds
Research has discovered retigabine may prevent noise-induced tinnitus -
News Pathway analysis may trigger new therapies to target rheumatoid arthritis
Scientists have made a discovery that could lead to new therapies for rheumatoid arthritis -
News ALM201 licensed to South Korean pharmaceutical for development
A novel anti-angiogenic peptide has been licensed to a South Korean firm for clinical development -
News Reducing levels of SGK1 could help treatment of depression
Researchers have found that reducing SGK1 levels can help with the treatment of depression -
News Antibody may be used to treat cancer of the blood
An antibody may be used to treat multiple myeloma -
News Synthetic protein could be foundation for future anti-venom vaccine
An engineered protein has the potential to be used as an anti-venom vaccine -
News Researchers develop most complete genetic profile of acute myeloid leukemia
A team of researchers have developed a complete genetic profile of acute myeloid leukemia -
News Telaprevir combination treatment shows high viral cure rate among specific patients
A combination treatment has been shown to have a high viral cure rate among certain hepatitis C patients -
News New F3 ultrasound system announced
A new ultrasound system has been announced -
News ALM201 licensed to South Korean pharmaceutical for development
A novel anti-angiogenic peptide has been licensed to a South Korean firm for clinical development -
News Video imaging used to identify effectiveness of rituximab on cancer
Video microscopy has been used to identify why a cancer treatment is so effective. -
News Post-operative adhesion in the pipelines for fibrosis treatment
An after-surgery adhesion could be used for the treatment of fibrosis. -
News Drug for advanced ovarian cancer does not offer value for money, Nice says
Nice has suggested a treatment for advanced ovarian cancer is not worth the cost. -
News First patient treated with new drug for multiple myeloma
A phase II clinical trial will continue to test the effectiveness of a new drug for multiple myeloma. -
News Breakthrough made on combination treatment for cystic fibrosis
A combination therapy for cystic fibrosis will now progress to a phase III study. -
News American Brachytherapy Society highlights benefits of new skin cancer treatment
A new treatment for non-melanoma skin cancer has been highlighted at an annual meeting. -
News T2 Biosystems makes advancements in hemostasis direct detection program
T2 Biosystems has announced progress in its hemostasis. product development program -
News RP5063 shows positive signs for the treatment of schizophrenia
A new drug has been shown to be potentially effective for the treatment of schizophrenia. -
News Clinical trial to test effectiveness of Pexa-Vec on liver cancer
A clinical trial is testing how well Paxa-Vec could act on liver cancer. -
News Chemists discover green microscopic algae could be used for biodiesel
Chemists have found that marine algae may be used to increase oil production -
News Brintellix could provide alternative treatment to MDD patients
A Danish study has found Brintellix could be an effective treatment for those with MDD. -
News Chemotherapy and surgery 'boosts survival' in advanced gastric cancer
Clinical trials have revealed that chemotherapy and surgery 'boosts survival' in advanced gastric cancer. -
News CMV treatment a success
Theraclone Sciences announces CMV trial results -
News CMV treatment a success
Theraclone Sciences announces CMV trial results -
News Alnylam partners up to commercialise hypercholesterolemia treatment
Alnylam is working with the Medicines Company to commercialise its hypercholesterolemia treatment. -
News Novavax reports respiratory tract vaccine success
Respiratory tract vaccine trial a success, Novavax indicates. -
News Careful phase-I trial planning 'saves time and delays'
The latest report from business intelligence firm Cutting Edge Information highlights the importance of planning carefully ahead of the initiation of phase-I trials. -
News Roche's Japanese arm gets green light for new arthritis drug trial
Chugai has been given the go-ahead to start clinical trials of its new arthritis treatment in Japan -
News Nagasaki University and Astellas announce new research agreement
NTDs are acknowledged to be a major global problem. -
News PharmaMar utilising technology to speed up clinical trials
The company will use clinical data management services from Medidata Solutions. -
News Phase 2 clinical trials expanded for Lou Gehrig's disease treatment
The Mayo Clinic will be involved in Phase II trials for a new ALS treatment. -
News New drug discovery company to focus on Alzheimer's
CoCo Therapeutics is a joint project between King's College London, The Wellcome Trust and Advent Venture Partners. -
News Gel developed for pressure-based drug delivery
A new pharmaceutical gel has been developed that is capable of releasing drugs when pressure is applied by the patient. -
News Progenitor Cell Therapy Initiate Study on Stem Cell Characterisation Technology
Sistemic and Leading CDMO, Progenitor Cell Therapy (PCT) Initiate Study on Novel Stem Cell Characterisation Technology -
News CGI Selected By Gilead Sciences, Inc. to Provide Clinical Trial Services
Comprehensive, biomarker-based patient profiling will help risk stratification, improve trial efficacy and provide biomarker driven insight regarding patient targeting and potential outcomes -
News Focus using Evogen technology in development of new diagnostics
The HyBeacons PCR probe technology will be used in the development of diagnostic tests for infectious diseases. -
News RegeneCure's Membrane Implant Shows 40% Accelerated Healing Time
RegeneCure announced the successful results of a clinical study in pets -
News Oncology clinical trial sites driven by patient enrollment needs
A study shows the number of sites required for an oncology clinical trial is dependent on the total patients needed. -
News New Drug Discovery Company CoCo Therapeutics Ltd Created to Progress Retinoic Acid Receptor Alpha Agonist for Alzheimers Diseas
Kings College London, The Wellcome Trust and Advent Venture Partners today announced the formation of a new UK biotechnology company. -
News Roche and BioLamina Start Collaboration to Develop Novel Cell Culture Systems
Research focus on investigation of laminin-based approaches -
News TetraGene Tries to Resuscitate Cylene's Anticancer Quadruplex Technologies
Cylene Pharmaceuticals is handing off its Phase II compound Quarfloxin and associated anticancer quadruplex-targeting technologies to oncology drug discovery and development company TetraGene -
News Two clinical trials look at plaque psoriasis treatment
Two impending clinical trials will look at plaque psoriasis treatment. -
News pSivida: Phase III clinical trials for uveitis treatment underway
pSivida has announced that Phase III clinical trials for uveitis treatment are now underway. -
News TransTech Pharma looking forward to Phase III clinical trials for TTP488
TransTech Pharma is looking forward to undertaking Phase III clinical trials to examine how effective TTP488 can be in the treatment of Alzheimer's disease. -
News New medical device coating approved for use in Japan
Bioline Coating with Recombumin Alpha has been approved for use in Japan. -
News BioGenes Reports Strong Growth of HCP Assay Development Business
Company is developing pre-optimized HCP assay kits -
News Avion Pharmaceuticals launches new iron supplement
A new iron supplement for women has been unveiled by US firm Avion Pharmaceuticals. -
News WCCT announces new population recruitment tool
WCCT has developed a new tool to help recruit patients to clinical trials. -
News Cytori Therapeutics receives European approval for Intravase
Cytori Therapeutics' new reagent for use when administering intravascular stem cells to patients has received a CE Mark of approval in Europe. -
News Endo signs with CRO for development of small molecules
India-based CRO GVK Biosciences will develop small molecules for Endo. -
News Shimadzu launches highly-sensitive gas chromatograph
Tracera promises to detect organic and inorganic trace compounds at the sub parts per million level. -
News Hydrix eyes Indian med-device cos for tech-transfer to develop products in POC diagnostics
Hydrix from Carnegie is now looking at tapping opportunities in technology transfer and joint product development for range of point-of-care (POC) diagnostics with companies in India.The company is a mobile-wireless technology major and an award winner... -
News Affordable treatment for common man should be the focus of all drug discovery: Dr T Ramaswami
Affordable treatment for the common man should be the focus of any drug development and the important aspect to be considered while engaging in the discovery of drugs is the effective cure for diseases. -
News FDA approval received for ultrasound imaging agent manufacturing site.
The FDA has approved Lantheus Medical's use of its JHS site for manufacturing of the ultrasound imaging agent Definitny Vial.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance